Fatores que estimulam a notificação de eventos adversos a medicamentos:uma revisão sistemática

Abstract

Underreporting of adverse drug events is the main limitation for promoting risk / benefit of using medicines, causing major impacts on public health, such as unnecessary spending for institutions and decreased patient safety. The objective of this study was to identify Identify the factors that encourage reporting of adverse drug events by health professionals.For this, a systematic review was conducted in LILACS, SciELO and PubMed in the period to June 2015. The search strategy is based on the model The PRISMA Statement by the use of scientific descriptors for identifying the original studies published evaluating the factors that stimulated the event notification. After fluctuating reading of the pre-selected studies, identify and analyze the interest variables. 193 potential relevant articles in the databases have been identified. After reading the titles and abstracts were eliminated 159 articles not fit the inclusion criteria. After reading in full were included 24 articles. We observed that the majority of studies contemplating mainly pharmaceuticals (n=15) and doctors (n=13). The main incentive factors for notification were: feedback (n=9); RAM severity (n=6) and training and continuing education (n=8). Educational interventions such as training and continuing education, along with other stimulus actions and individual feedback stimulate notification EAM by health professionals